2019

London, UK

Day One
Wednesday March 21st, 2018

Day Two
Thursday March 22nd, 2018

08.30
Breakfast & Networking

09.25
Chairman’s Opening Remarks

  • Michael Holers Scoville Professor & Head, Division of Rheumatology, University of Colorado

09.30
Complement-based Drug Development Round Tables Key Takeaways

Synopsis

Your opportunity to gather all the information from the previous day’s roundtables. Leave this exciting session with new solutions for your challenges.

10.00
Advances in Understanding of Disease Pathogenesis in Rheumatoid Arthritis and Systemic Lupus Erythematosus Open Up New Opportunities for Complement Therapeutics

  • Michael Holers Scoville Professor & Head, Division of Rheumatology, University of Colorado

10.30
Dual blockade of complement C3/C5 and TLR/CD14 as a Novel Treatment Approach for Sepsis and SIRS.

  • Tom Mollnes Professor of Immunology and Leader, Complement Research Group, University of Oslo

11.00
Morning Refreshments & Networking

Applying Lessons Learned to the Next Generation of Complement Inhibitors

12.00
RA101495 and Macrocyclic Peptides for Disorders of Complement Regulation

12.30
Coversin: The Role in the Treatment of Paroxysmal Nocturnal Hemoglobinuria and Atypical Hemolytic Uremic Syndrome

13.00
Lunch & Networking

14.00
Development of BIVV009 for the Treatment of Patients with Primary Cold Agglutinin Disease

14.30
Development of an Alternative Complement Pathway Inhibitors and Assessment of the Potential Infection Risk

15.00
Chairman’s Closing Remarks & Close of Summit

  • Michael Holers Scoville Professor & Head, Division of Rheumatology, University of Colorado